23andMe Cuts Some Staff | GenomeWeb

NEW YORK (GenomeWeb News) – California consumer genomics company 23andMe has confirmed that it has laid off some of its workers as part of an effort to maintain competitiveness and respond to a weak economy, the company said.

The firm did not say how many positions have been cut or what parts of the company were hit by the layoffs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.